SLIT2 has previously been reported to act as a tumor-suppressor in lung cancer, thyroid cancer, gastric cancer, acute promyelocytic leukemia and other types of cancer [19, 20, 23–25]. This evidence concerns the gene SLIT2 and acute promyelocytic leukemia.